Showing 231 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Study Evaluating Effectiveness and Adherence of Inclisiran Plus Standard of Care (SoC) Lipid-lowering Therapy Compared to SoC in ASCVD

Primary Hypercholesterolemia, Mixed Dyslipidemia United Arab Emirates
Austria
Switzerland
China
Israel
View All

Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies

B-cell Non-Hodgkin Lymphoma (B-NHL), B-cell Acute Lymphoblastic Leukemia (B-ALL) Phase 1 United States
Spain
Belgium
Japan
France
Italy
Singapore
Israel
View All

A Real-world Study to Assess Safety and Effectiveness of Secukinumab in Pediatric Plaque Psoriasis Patients in China

Moderate to Severe Chronic Plaque Psoriasis China

Phase IIIb, Open-label, Multi-center Study to Evaluate Safety, Tolerability and Efficacy of OAV101 Administered Intrathecally to Participants With SMA Who Discontinued Treatment With Nusinersen or Risdiplam

Spinal Muscular Atrophy Phase 3 Spain
Japan
Canada
Netherlands
View All

Asciminib Monotherapy, With Dose Escalation, for 2nd Line Chronic Myelogenous Leukemia

Chronic Myelogenous Leukemia - Chronic Phase Phase 2 United States

Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical Remission

Giant Cell Arteritis Phase 3 Germany

Impact of Mayzent on aSPMS Patients in a Long-term NIS in Italy

Active Secondary Progressive Multiple Sclerosis Italy

A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting

Hypercholesterolemia Germany

Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events

Coronary Artery Disease Phase 3 United States
Australia
India
Spain
China
United Kingdom
Hungary
Korea, Republic of
Brazil
Ireland
Switzerland
Belgium
Canada
France
Italy
Chile
View All

Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation

KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small Cell Lung, Carcinoma, Non-Small-Cell Lung, Non-Small Cell Lung Cancer, Non-Small Cell Lung Carcinoma, Nonsmall Cell Lung Cancer, Colorectal Cancer, Colorectal Carcinoma, Colorectal Neoplasms, Colorectal Tumors, Neoplasms, Colorectal Phase 1, Phase 2 United States
France
Germany
Belgium
Spain
Italy
Korea, Republic of
Singapore
View All